Innate Pharma SA Adjustments For Increase Decrease In Employee Benefit Liabilities
Innate Pharma SA (IPHA) reported Adjustments For Increase Decrease In Employee Benefit Liabilities of -EUR 807.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities · last filed 2026-04-01
| Period end | Adjustments For Increase Decrease In Employee Benefit Liabilities 6 month | Adjustments For Increase Decrease In Employee Benefit Liabilities 12 month |
|---|---|---|
| 2025-12-31 | -807.00K EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 79.00K EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 324.00K EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 145.00K EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 285.00K EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 83.00K EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 365.00K EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 192.00K EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 437.00K EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 268.00K EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 216.00K EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 264.00K EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 685.00K EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 477.00K EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 381.00K EUR 20-F · filed 2020-04-24 |